Sponsored by

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1726 to 1750 of about 5880

Previous 25

Website Changes

01/19/2016

Neurosurgeons Evaluate Precision Laser Treatment Of Brain Tumors at UC San Diego Health

01/07/2016

Oncurious NV Announces FDA Acceptance of Investigational New Drug (IND) Application for a Phase I/IIa Study with TB-403 for the Treatment of Pediatric Brain Tumors

01/06/2016

Novocure Files Premarket Approval Supplement Application With FDA for Second Generation Optune System

01/05/2016

Intra-arterial administration improves temozolomide delivery and efficacy in a model of intracerebral metastasis, but has unexpected brain toxicity.

01/05/2016

Association between human cytomegalovirus infection and histone acetylation level in various histological types of glioma.

01/05/2016

Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies.

01/04/2016

SPAGNOLETTI & ASSOCIATES RAISING FUNDS FOR MUSELLA FOUNDATION

01/03/2016

Florida Brain Tumor Associations ` 1st Annual Gala

12/31/2015

Added a nice survivor story with a picture of a nice lady wearing the Optune device. In 1 photo she shows it off, in the other she hides it.

12/24/2015

The Musella Foundation has awarded another pediatric brain tumor research grant

12/23/2015

Study Finds Mechanism That Causes Normal Cells to Become Cancerous

12/21/2015

Recurrent venous thromboembolism in glioblastoma.

12/20/2015

IBTA Newsletter

12/19/2015

Brain cancer patient beats odds with experimental treatment

12/15/2015

Experimental drugs that change energy supply in cells could slow brain tumor growth

12/15/2015

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma

12/14/2015

New Data on Tumor Treating Fields’ Anti-Mitotic Mechanism of Action Published in Scientific Reports

12/14/2015

Roche`s Alecensa Granted Accelerated FDA Approval in Lung Cancer

12/13/2015

Patient with Brain Tumor Responds Dramatically to Targeted Therapy

12/12/2015

The Musella Foundation has awarded a pediatric brain tumor research grant

12/12/2015

A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas.

12/12/2015

First Patient Enrolled in Toca 5, Tocagen’s Phase 2/3 Clinical Trial in Patients with Recurrent Glioblastoma or Anaplastic Astrocytoma

12/08/2015

Novocure (NVCR) Issues Positive Update on TTFields Study in Certain Glioblastoma Patients

11/27/2015

Existing Drug May Limit Recurrence and Metastasis of Glioblastoma Multiforme

11/27/2015

Experimental brain cancer treatment offers family hope

Our privacy / cookie policy has changed.
Click HERE to read it!